OncoSil Medical Ltd Launches Security Purchase Plan for Shareholders

OncoSil Medical Ltd ( (AU:OSL) ) has issued an update.

OncoSil Medical Ltd has announced the opening of a Security Purchase Plan (SPP) for eligible shareholders, primarily in Australia and New Zealand. This plan allows shareholders to purchase up to $100,000 of new fully paid OncoSil ordinary shares without incurring brokerage or transaction costs. The offer includes one free attaching option for every new share issued, with the options having an exercise price of $0.003 each and an expiry date of July 31, 2027. The SPP aims to strengthen OncoSil’s financial position as it continues to commercialize its innovative cancer treatment technology.

More about OncoSil Medical Ltd

OncoSil Medical Ltd is a company specializing in cancer treatment devices, particularly the OncoSil™ brachytherapy device. This device is used for treating locally advanced unresectable pancreatic cancer, a condition with a poor prognosis and typically diagnosed at a later stage. The OncoSil™ device has received breakthrough device designation in the EU, UK, and US, and is approved for sale in over 30 countries, including the EU, UK, Türkiye, and Israel.

Technical Sentiment Signal: Sell

Current Market Cap: A$5.53B

Learn more about OSL stock on TipRanks’ Stock Analysis page.